Wells Fargo’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $338K | Sell |
58,307
-112,489
| -66% | -$746K | ﹤0.01% | 4366 |
|
|
2025
Q4 | $1.34M | Buy |
170,796
+73,600
| +76% | +$579K | ﹤0.01% | 3740 |
|
|
2025
Q3 | $791K | Buy |
97,196
+16,830
| +21% | +$112K | ﹤0.01% | 3970 |
|
|
2025
Q2 | $375K | Buy |
80,366
+10,485
| +15% | +$48K | ﹤0.01% | 4357 |
|
|
2025
Q1 | $384K | Sell |
69,881
-9,155
| -12% | -$37K | ﹤0.01% | 4270 |
|
|
2024
Q4 | $268K | Buy |
79,036
+22,050
| +39% | +$70.9K | ﹤0.01% | 4607 |
|
|
2024
Q3 | $162K | Sell |
56,986
-2,667
| -4% | -$6.85K | ﹤0.01% | 4719 |
|
|
2024
Q2 | $134K | Buy |
59,653
+7,409
| +14% | +$14.9K | ﹤0.01% | 4768 |
|
|
2024
Q1 | $115K | Buy |
52,244
+7,402
| +17% | +$19.1K | ﹤0.01% | 4809 |
|
|
2023
Q4 | $105K | Buy |
44,842
+7,853
| +21% | +$14.5K | ﹤0.01% | 4864 |
|
|
2023
Q3 | $68.8K | Sell |
36,989
-28,900
| -44% | -$66.2K | ﹤0.01% | 4999 |
|
|
2023
Q2 | $173K | Buy |
65,889
+29,952
| +83% | +$76.3K | ﹤0.01% | 4678 |
|
|
2023
Q1 | $58.6K | Buy |
35,937
+24,824
| +223% | +$31.1K | ﹤0.01% | 5083 |
|
|
2022
Q4 | $14.8K | Sell |
11,113
-2,445
| -18% | -$3.45K | ﹤0.01% | 5392 |
|
|
2022
Q3 | $21K | Sell |
13,558
-1,189
| -8% | -$1.97K | ﹤0.01% | 5376 |
|
|
2022
Q2 | $23K | Buy |
14,747
+3,634
| +33% | +$7.67K | ﹤0.01% | 5388 |
|
|
2022
Q1 | $28K | Sell |
11,113
-566
| -5% | -$1.38K | ﹤0.01% | 5893 |
|
|
2021
Q4 | $34K | Buy |
11,679
+9,113
| +355% | +$19.7K | ﹤0.01% | 6148 |
|
|
2021
Q3 | $6K | Buy |
2,566
+1,000
| +64% | +$2.9K | ﹤0.01% | 6341 |
|
|
2021
Q2 | $6K | Sell |
1,566
-8,398
| -84% | -$32K | ﹤0.01% | 6301 |
|
|
2021
Q1 | $45K | Sell |
9,964
-33,827
| -77% | -$182K | ﹤0.01% | 5860 |
|
|
2020
Q4 | $215K | Buy |
43,791
+18,204
| +71% | +$91.1K | ﹤0.01% | 5045 |
|
|
2020
Q3 | $151K | Sell |
25,587
-9,154
| -26% | -$36.6K | ﹤0.01% | 5098 |
|
|
2020
Q2 | $93K | Buy |
34,741
+9,816
| +39% | +$34.2K | ﹤0.01% | 5256 |
|
|
2020
Q1 | $49K | Sell |
24,925
-44,031
| -64% | -$189K | ﹤0.01% | 5348 |
|
|
2019
Q4 | $486K | Buy |
68,956
+18,065
| +35% | +$149K | ﹤0.01% | 4397 |
|
|
2019
Q3 | $501K | Buy |
50,891
+8,918
| +21% | +$100K | ﹤0.01% | 4382 |
|
|
2019
Q2 | $480K | Buy |
41,973
+29,682
| +241% | +$312K | ﹤0.01% | 4408 |
|
|
2019
Q1 | $123K | Buy |
12,291
+8,994
| +273% | +$115K | ﹤0.01% | 5060 |
|
|
2018
Q4 | $56K | Buy |
3,297
+2,362
| +253% | +$47.4K | ﹤0.01% | 5483 |
|
|
2018
Q3 | $16K | Buy |
+935
| New | +$20.3K | ﹤0.01% | 5886 |
|
Other funds holding XERS
VCM
RA
N
VPM
